PubMed

Fluvastatin/fenofibrate vs. simvastatin/ezetimibe in patients with metabolic syndrome: different effects on LDL-profiles.

Westerink J, Visseren FL.

Eur J Clin Invest. 2009 Nov 12. [Epub ahead of print] No abstract available. PMID: 19912317 [PubMed - as supplied by publisher]Related articles

Acute and chronic renal artery stenosis.

van de Donk NW, Kooij N, Visseren FL.

Eur Heart J. 2009 Oct 23. [Epub ahead of print] No abstract available. PMID: 19854723 [PubMed - as supplied by publisher]Related articles

The effects of the PPAR-gamma agonist pioglitazone on plasma concentrations of circulating vasoactive factors in type II diabetes mellitus.

de Boer RA, Martens FM, Kuipers I, Boomsma F, Visseren FL.

J Hum Hypertens. 2009 Oct 22. [Epub ahead of print] No abstract available. PMID: 19847195 [PubMed - as supplied by publisher]Related articles

Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands.

Pijlman AH, Huijgen R, Verhagen SN, Imholz BP, Liem AH, Kastelein JJ, Abbink EJ, Stalenhoef AF, Visseren FL.

Atherosclerosis. 2009 Sep 15. [Epub ahead of print]PMID: 19818960 [PubMed - as supplied by publisher]Related articles

[Cardiovascular prevention: begin young]

Visseren FL.

Ned Tijdschr Geneeskd. 2009;153. pii: Ned Tijdschr geneesk. 2009;153:B368. Dutch. PMID: 19785806 [PubMed - in process]Related articles

Obesity and cancer: the role of dysfunctional adipose tissue.

van Kruijsdijk RC, van der Wall E, Visseren FL.

Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2569-78. Epub 2009 Sep 15.PMID: 19755644 [PubMed - in process]Related articles

Blood pressure and progression of cerebral atrophy in patients with vascular disease.

Vlek AL, Visseren FL, Kappelle LJ, Geerlings MI, Vincken KL, Mali WP, van der Graaf Y; SMART Study Group.

Am J Hypertens. 2009 Nov;22(11):1183-9. Epub 2009 Sep 10.PMID: 19745819 [PubMed - indexed for MEDLINE]Related articles

Blood pressure and decline in kidney function in patients with atherosclerotic vascular disease: a cohort study.

Vlek AL, van der Graaf Y, Braam B, Moll FL, Nathoe HM, Visseren FL; SMART Study Group.

Am J Kidney Dis. 2009 Nov;54(5):820-9. Epub 2009 Sep 6.PMID: 19733947 [PubMed - indexed for MEDLINE]Related articles

Letter by Westerink and Visseren regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation".

Westerink J, Visseren FL.

Circulation. 2009 Sep 1;120(9):e66; author reply e69-70. No abstract available. PMID: 19720942 [PubMed - indexed for MEDLINE]Related articles

Intracellular infections enhance interleukin-6 and plasminogen activator inhibitor 1 production by cocultivated human adipocytes and THP-1 monocytes.

Bouwman JJ, Diepersloot RJ, Visseren FL.

Clin Vaccine Immunol. 2009 Aug;16(8):1222-7. Epub 2009 Jun 24.PMID: 19553556 [PubMed - indexed for MEDLINE]Related articles

Blood pressure and white matter lesions in patients with vascular disease: the SMART-MR study.

Vlek AL, Visseren FL, Kappelle LJ, Witkamp TD, Vincken KL, Mali WP, van der Graaf Y; SMART Study Group.

Curr Neurovasc Res. 2009 Aug;6(3):155-62. Epub 2009 Aug 1.PMID: 19534721 [PubMed - in process]Related articles

Role of adipose tissue in haemostasis, coagulation and fibrinolysis.

Faber DR, de Groot PG, Visseren FL.

Obes Rev. 2009 Sep;10(5):554-63. Epub 2009 May 12.PMID: 19460118 [PubMed - in process]Related articles

Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c.

Hajer GR, van der Graaf Y, Bots ML, Algra A, Visseren FL; SMART Study Group.

Eur J Clin Invest. 2009 Aug;39(8):680-8. Epub 2009 May 12.PMID: 19453647 [PubMed - in process]Related articles

Relation of common carotid intima-media thickness with left ventricular mass caused by shared risk factors for hypertrophy.

Meijs MF, Doevendans PA, Cramer MJ, Vonken EJ, Velthuis BK, van der Graaf Y, Visseren FL, Mali WP, Bots ML; SMART Study group.

J Am Soc Echocardiogr. 2009 May;22(5):499-504. Epub 2009 Mar 9.PMID: 19269135 [PubMed - indexed for MEDLINE]Related articles

Cognitive dysfunction and its clinical and radiological determinants in patients with symptomatic arterial disease and diabetes.

Tiehuis AM, Mali WP, van Raamt AF, Visseren FL, Biessels GJ, van Zandvoort MJ, Kappelle LJ, van der Graaf Y; SMART Study Group.

J Neurol Sci. 2009 Aug 15;283(1-2):170-4. Epub 2009 Mar 6.PMID: 19268970 [PubMed - indexed for MEDLINE]Related articles

Metabolic syndrome and vascular risk in patients with peripheral arterial occlusive disease.

Vlek AL, van der Graaf Y, Sluman MA, Moll FL, Visseren FL; SMART Study Group.

J Vasc Surg. 2009 Jul;50(1):61-9. Epub 2009 Feb 15.PMID: 19223144 [PubMed - indexed for MEDLINE]Related articles

Unrecognised myocardial infarction in subjects at high vascular risk: prevalence and determinants.

Meijs MF, Bots ML, Cramer MJ, Vonken EJ, Velthuis BK, van der Graaf Y, Visseren FL, Mali WP, Doevendans PA; SMART Study group.

Heart. 2009 May;95(9):728-32. Epub 2009 Feb 12.PMID: 19218261 [PubMed - indexed for MEDLINE]Related articles

Intracellular labile iron promotes firm adhesion of human monocytes to endothelium under flow and transendothelial migration Iron and monocyte-endothelial cell interactions.

Kartikasari AE, Visseren FL, Marx JJ, van Mullekom S, Kats-Renaud JH, Asbeck BS, Ulfman LH, Georgiou NA.

Atherosclerosis. 2009 Aug;205(2):369-75. Epub 2008 Dec 30.PMID: 19187935 [PubMed - in process]Related articles

Social support and change in vascular risk factors in patients with clinical manifestations of vascular diseases.

Sol BG, van der Graaf Y, Goessens BM, Visseren FL.

Eur J Cardiovasc Nurs. 2009 Jun;8(2):137-43. Epub 2008 Dec 3.PMID: 19054719 [PubMed - indexed for MEDLINE]Related articles

[Doubts regarding the existence and clinical relevance of 'new' risk determinants of cardiovascular disease are unfounded]

Visseren FL, van der Graaf Y.

Ned Tijdschr Geneeskd. 2008 Nov 8;152(45):2480; author reply 2480-1. Dutch. No abstract available. PMID: 19051802 [PubMed - indexed for MEDLINE]Related articles

Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the rating atherosclerotic disease change by imaging with a new CETP inhibitor (RADIANCE) trials.

Vergeer M, Bots ML, van Leuven SI, Basart DC, Sijbrands EJ, Evans GW, Grobbee DE, Visseren FL, Stalenhoef AF, Stroes ES, Kastelein JJ.

Circulation. 2008 Dec 9;118(24):2515-22. Epub 2008 Nov 24. Erratum in: Circulation. 2009 Feb 10;119(5):e197. PMID: 19029469 [PubMed - indexed for MEDLINE]Related articles

Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy.

Westerweel PE, Visseren FL, Hajer GR, Olijhoek JK, Hoefer IE, de Bree P, Rafii S, Doevendans PA, Verhaar MC.

Eur Heart J. 2008 Nov;29(22):2808-17. Epub 2008 Sep 28.PMID: 18824462 [PubMed - indexed for MEDLINE]Related articlesFree article

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.

Hajer GR, van Haeften TW, Visseren FL.

Eur Heart J. 2008 Dec;29(24):2959-71. Epub 2008 Sep 5. Review.PMID: 18775919 [PubMed - indexed for MEDLINE]Related articles

Relation of epicardial and pericoronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography.

Gorter PM, de Vos AM, van der Graaf Y, Stella PR, Doevendans PA, Meijs MF, Prokop M, Visseren FL.

Am J Cardiol. 2008 Aug 15;102(4):380-5. Epub 2008 May 24.PMID: 18678291 [PubMed - indexed for MEDLINE]Related articles

The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial.

Olijhoek JK, Hajer GR, van der Graaf Y, Dallinga-Thie GM, Visseren FL.

J Cardiovasc Pharmacol. 2008 Aug;52(2):145-50.PMID: 18670365 [PubMed - indexed for MEDLINE]Related articles

A pilot-study to identify the feasibility of an Internet-based coaching programme for changing the vascular risk profile of high-risk patients.

Goessens BM, Visseren FL, de Nooijer J, van den Borne HW, Algra A, Wierdsma J, van der Graaf Y; SMART Study Group.

Patient Educ Couns. 2008 Oct;73(1):67-72. Epub 2008 Jul 18.PMID: 18639410 [PubMed - indexed for MEDLINE]Related articles

Metabolic syndrome and incidence of type 2 diabetes in patients with manifest vascular disease.

Wassink AM, Van Der Graaf Y, Soedamah-Muthu SS, Spiering W, Visseren FLj; Smart Study Group.

Diab Vasc Dis Res. 2008 Jun;5(2):114-22.PMID: 18537099 [PubMed - indexed for MEDLINE]Related articles

The effect of statin alone or in combination with ezetimibe on postprandial lipoprotein composition in obese metabolic syndrome patients.

Hajer GR, Dallinga-Thie GM, van Vark-van der Zee LC, Visseren FL.

Atherosclerosis. 2009 Jan;202(1):216-24. Epub 2008 Apr 26.PMID: 18533158 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular events and all-cause mortality by albuminuria and decreased glomerular filtration rate in patients with vascular disease.

Vlek AL, van der Graaf Y, Spiering W, Algra A, Visseren FL; SMART study group.

J Intern Med. 2008 Oct;264(4):351-60. Epub 2008 Jun 3.PMID: 18522685 [PubMed - indexed for MEDLINE]Related articles

Intra-abdominal fat and metabolic syndrome are associated with larger infrarenal aortic diameters in patients with clinically evident arterial disease.

Gorter PM, Visseren FL, Moll FL, van der Graaf Y; SMART Study Group.

J Vasc Surg. 2008 Jul;48(1):114-20. Epub 2008 Apr 28.PMID: 18440755 [PubMed - indexed for MEDLINE]Related articles

Lipid-lowering therapy does not affect the postprandial drop in high density lipoprotein-cholesterol (HDL-c) plasma levels in obese men with metabolic syndrome: a randomized double blind crossover trial.

Hajer GR, Dallinga-Thie GM, van Vark-van der Zee LC, Olijhoek JK, Visseren FL.

Clin Endocrinol (Oxf). 2008 Dec;69(6):870-7. Epub 2008 Apr 3.PMID: 18394022 [PubMed - indexed for MEDLINE]Related articles

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, Visseren FL, Sijbrands EJ, Trip MD, Stein EA, Gaudet D, Duivenvoorden R, Veltri EP, Marais AD, de Groot E; ENHANCE Investigators.

N Engl J Med. 2008 Apr 3;358(14):1431-43. Epub 2008 Mar 30. Erratum in: N Engl J Med. 2008 May 1;358(18):1977. PMID: 18376000 [PubMed - indexed for MEDLINE]Related articlesFree article

Diabetes increases atrophy and vascular lesions on brain MRI in patients with symptomatic arterial disease.

Tiehuis AM, van der Graaf Y, Visseren FL, Vincken KL, Biessels GJ, Appelman AP, Kappelle LJ, Mali WP; SMART Study Group.

Stroke. 2008 May;39(5):1600-3. Epub 2008 Mar 27.PMID: 18369167 [PubMed - indexed for MEDLINE]Related articlesFree article

Infection-induced inflammatory response of adipocytes in vitro.

Bouwman JJ, Visseren FL, Bouter KP, Diepersloot RJ.

Int J Obes (Lond). 2008 Jun;32(6):892-901. Epub 2008 Mar 18.PMID: 18347604 [PubMed - indexed for MEDLINE]Related articles

Determinants of CRP level in statin-treated patients.

Liem AH, van de Woestijne AP, Zwinderman AH, Visseren FL, Jukema JW.

Curr Med Res Opin. 2008 Apr;24(4):1065-8. Epub 2008 Feb 28.PMID: 18312742 [PubMed - indexed for MEDLINE]Related articles

Vascular consequences of metabolic syndrome in early life.

Visseren FL.

Eur Heart J. 2008 Mar;29(6):693-4. Epub 2008 Feb 27. No abstract available. PMID: 18308691 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.

Vlek AL, van der Graaf Y, Spiering W, Visseren FL; SMART study group.

J Hum Hypertens. 2008 May;22(5):358-65. Epub 2008 Feb 14.PMID: 18273039 [PubMed - indexed for MEDLINE]Related articles

[Infection-induced vascular disease: little evidence according to the Koch's postulates]

Visseren FL, Spiering W, Hoepelman IM.

Ned Tijdschr Geneeskd. 2007 Dec 29;151(52):2883-7. Review. Dutch. PMID: 18257433 [PubMed - indexed for MEDLINE]Related articles

The role of self-efficacy in vascular risk factor management: a randomized controlled trial.

Sol BG, van der Graaf Y, van der Bijl JJ, Goessens BM, Visseren FL.

Patient Educ Couns. 2008 May;71(2):191-7. Epub 2008 Feb 1.PMID: 18242934 [PubMed - indexed for MEDLINE]Related articles

Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm.

Wassink AM, van der Graaf Y, Olijhoek JK, Visseren FL; SMART Study Group.

Eur Heart J. 2008 Jan;29(2):213-23.PMID: 18199567 [PubMed - indexed for MEDLINE]Related articlesFree article

The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study.

Soedamah-Muthu SS, Visseren FL, Algra A, van der Graaf Y; SMART Study Group.

Diabet Med. 2008 Jan;25(1):51-7.PMID: 18199132 [PubMed - indexed for MEDLINE]Related articles

The impact of site and extent of clinically evident cardiovascular disease and atherosclerotic burden on new cardiovascular events in patients with Type 2 diabetes. The SMART study.

Gorter PM, Visseren FL, Algra A, van der Graaf Y; SMART Study Group.

Diabet Med. 2007 Dec;24(12):1352-60.PMID: 18042079 [PubMed - indexed for MEDLINE]Related articles

The effect of leisure-time physical activity on the presence of metabolic syndrome in patients with manifest arterial disease. The SMART study.

Brouwer BG, Visseren FL, van der Graaf Y; SMART Study Group.

Am Heart J. 2007 Dec;154(6):1146-52. Epub 2007 Sep 12.PMID: 18035088 [PubMed - indexed for MEDLINE]Related articles

Low plasma levels of adiponectin are associated with low risk for future cardiovascular events in patients with clinical evident vascular disease.

Hajer GR, van der Graaf Y, Olijhoek JK, Edlinger M, Visseren FL.

Am Heart J. 2007 Oct;154(4):750.e1-7.PMID: 17893004 [PubMed - indexed for MEDLINE]Related articles

Quantification of epicardial and peri-coronary fat using cardiac computed tomography; reproducibility and relation with obesity and metabolic syndrome in patients suspected of coronary artery disease.

Gorter PM, van Lindert AS, de Vos AM, Meijs MF, van der Graaf Y, Doevendans PA, Prokop M, Visseren FL.

Atherosclerosis. 2008 Apr;197(2):896-903. Epub 2007 Sep 19.PMID: 17884060 [PubMed - indexed for MEDLINE]Related articles

Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial.

Bots ML, Visseren FL, Evans GW, Riley WA, Revkin JH, Tegeler CH, Shear CL, Duggan WT, Vicari RM, Grobbee DE, Kastelein JJ; RADIANCE 2 Investigators.

Lancet. 2007 Jul 14;370(9582):153-60.PMID: 17630038 [PubMed - indexed for MEDLINE]Related articles

Defining the metabolic syndrome: Resolving unresolved issues?

Olijhoek JK, van der Graaf Y, Haffner SM, Visseren FL; for the SMART Study Group.

Eur J Intern Med. 2007 Jul;18(4):309-13.PMID: 17574106 [PubMed - in process]Related articles

Abdominal fat and risk of coronary heart disease in patients with peripheral arterial disease.

Brouwer BG, Visseren FL, Stolk RP, van der Graaf Y; SMART Study Group.

Obesity (Silver Spring). 2007 Jun;15(6):1623-30.PMID: 17558001 [PubMed - indexed for MEDLINE]Related articles

Carotid arterial stiffness is marginally higher in the metabolic syndrome and markedly higher in type 2 diabetes mellitus in patients with manifestations of arterial disease.

Martens FM, van der Graaf Y, Dijk JM, Olijhoek JK, Visseren FL.

Atherosclerosis. 2008 Apr;197(2):646-53. Epub 2007 Mar 19.PMID: 17374372 [PubMed - indexed for MEDLINE]Related articles

Asymptomatic carotid artery stenosis and the risk of new vascular events in patients with manifest arterial disease: the SMART study.

Goessens BM, Visseren FL, Kappelle LJ, Algra A, van der Graaf Y.

Stroke. 2007 May;38(5):1470-5. Epub 2007 Mar 15.PMID: 17363718 [PubMed - indexed for MEDLINE]Related articlesFree article